QL0911

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for QL0911, covering 2022-11-23 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients [Phase 3]